Evidence map›Paper›PMID 22647690›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA

Drug-drug interaction through molecular structure similarity analysis.

Santiago Vilar, Rave Harpaz, Eugenio Uriarte, Lourdes Santana, Raul Rabadan, Carol Friedman

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. DDI-CYP: Metabolism ensemble models for drug-drug interaction predictions.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Santiago VilarDepartment of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA. qosanti@yahoo.es
Rave Harpaz
Eugenio Uriarte
Lourdes Santana
Raul Rabadan
Carol Friedman

Funding

Pharmacovigilence using Natural Language Processing, Statistics, and the EHRR01LM010016 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FRIEDMAN, CAROL · 2009 to 2016
$3.4M
A Biomedical Natural Language Processing ResourceR01LM008635 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FRIEDMAN, CAROL · 2005 to 2008
$2.1M
Integrated discovery and hypothesis testing of new associations in rare diseasesR01LM010140 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RABADAN, RAUL · 2009 to 2010
$1.1M
NLM NIH HHS 1R01LM010140-01NLM NIH HHS R01 LM008635NLM NIH HHS R01 LM010016NLM NIH HHS R01 LM010016-0S1NLM NIH HHS R01 LM010016-0S2NLM NIH HHS R01 LM010140
6 · The paper itself

Abstract

backgroundDrug-drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for patient safety but is very challenging. Currently, the US Food and Drug Administration and pharmaceutical companies are showing great interest in the development of improved tools for identifying DDIs.

methodsWe present a new methodology applicable on a large scale that identifies novel DDIs based on molecular structural similarity to drugs involved in established DDIs. The underlying assumption is that if drug A and drug B interact to produce a specific biological effect, then drugs similar to drug A (or drug B) are likely to interact with drug B (or drug A) to produce the same effect. DrugBank was used as a resource for collecting 9454 established DDIs. The structural similarity of all pairs of drugs in DrugBank was computed to identify DDI candidates.

resultsThe methodology was evaluated using as a gold standard the interactions retrieved from the initial DrugBank database. Results demonstrated an overall sensitivity of 0.68, specificity of 0.96, and precision of 0.26. Additionally, the methodology was also evaluated in an independent test using the Micromedex/Drugdex database.

conclusionThe proposed methodology is simple, efficient, allows the investigation of large numbers of drugs, and helps highlight the etiology of DDI. A database of 58 403 predicted DDIs with structural evidence is provided as an open resource for investigators seeking to analyze DDIs.

Indexed as

Drug InteractionsModels, MolecularPharmacovigilanceDatabases, PharmaceuticalDrug-Related Side Effects and Adverse ReactionsForecastingHumansMolecular StructurePharmaceutical PreparationsROC CurveSensitivity and SpecificityUnited StatesPharmaceutical Preparations

Identifiers

PMID22647690
PMCPMC3534468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.